Manage settings
MENU
About this site
In het Nederlands
Home
Researchers
Projects
Organisations
Publications
Infrastructure
Contact
Research Explorer
Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.
Researcher
Geert Berx
Profile
Projects
Publications
Activities
Awards & Distinctions
Results
:
ALL
(
50
)
Order By :
Title (a-z)
Title (a-z)
Chronological by starting year (new to old)
As
Promotor-spokesperson
01 January 2023 → 31 December 2026
Dissecting stromal-cancer cell interactions at the perivascular niche to detect and intercept the early metastatic process.
Funding: Regional and community funding: Special Research Fund
As
Promotor
01 March 2021 → 28 February 2025
Defining the role of ZEB1 in tumour initiation and progression of basal-like breast cancer
Funding: Funding by bilateral agreement (private and foundations)
01 January 2009 → 31 December 2012
EMT inducers of the Snail transcriptionfactor family driving malignant skin cancer progression.
Funding: Funding by bilateral agreement (private and foundations)
01 January 2012 → 31 October 2016
EMT, stem cells and inflammation: a malignant cocktail for cancer
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 31 December 2018
EMT the ultimate inhibiting mechanism of cell death during cancer development
Funding: Research Foundation - Flanders (FWO)
01 January 2007 → 31 October 2013
Epithelial breast cancer: from molecular signaling pathways to clinical application
Funding: Regional and community funding: Special Research Fund
01 October 2010 → 30 September 2016
Functional characterization of the EMT inducer, ZEB2/SIP1 during definitive hematopoiesis
Fellow: Steven Goossens
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 September 2014 → 31 August 2018
Identification and characterization of residual melanoma cells to MAPL-targeted therapy: a search for biomarkers and novel therapeutic opportunities
Funding: Research Foundation - Flanders (FWO)
01 January 2016 → 31 December 2018
Investigate the regulation of ZEB1/2 protein stability using an siRNA library screening
Funding: Research Foundation - Flanders (FWO)
01 January 2012 → 31 December 2014
Investigation of the in vivo role of the EMT-inducing transcription factors and ZEB2 ZEB1 in the development and progression of melanoma and non-melanoma skin cancers
Funding: Research Foundation - Flanders (FWO)
01 October 2013 → 30 September 2017
In vivo analysis of the role of a newly identified screenings hit in breast epithelial homeostasis and basal breast cancer progression
Fellow: Eva De Smedt
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 November 2019 → 31 December 2022
In vivo analysis of the role of EMT in triple-negative breast cancer initiation and immune modulation.
Fellow: Jan Van Landeghem
Funding: Research Foundation - Flanders (FWO)
01 January 2012 → 31 December 2017
Microenvironmental regulation of cancer progression
Funding: Research Foundation - Flanders (FWO)
01 January 2008 → 30 December 2010
Research on regulation of Snail and delta EF1 transcriptionfactors during EMT
Funding: Research Foundation - Flanders (FWO)
01 October 2013 → 30 September 2017
Role of Nanos-3 in cancer progression
Fellow: Evi De Keuckelaere
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 October 2013 → 30 September 2015
Role of Nanos-3 in cancer progression
Funding: Regional and community funding: Special Research Fund
01 October 2013 → 30 September 2018
Role of the EMT transcription factor ZEB2 in the immune response associated with skin pathologies
Fellow: Bieke Soen
Funding: Research Foundation - Flanders (FWO), Regional and community funding: Special Research Fund
01 January 2013 → 31 December 2018
Role of the Zeb family of transcription factors in T-cell Acute Lymphoblastic Leukemia (T-ALL)
Funding: Research Foundation - Flanders (FWO)
01 January 2013 → 31 December 2015
Role of ZEB2 in T-cell acute lymphoblastic leukemia (T-ALL) initiation and Progression
Funding: Funding by bilateral agreement (private and foundations)
01 January 2024 → 31 December 2025
Study of Cellular Plasticity during Malignant Cancer Progression
Funding: Regional and community funding: Special Research Fund
01 October 2011 → 30 June 2016
Study of the in vivo role of Snail in melanocyte stem cell homeostasis and melanoma during initiation and progression
Fellow: Niels Vandamme
Funding: Regional and community funding: IWT/VLAIO
01 January 2018 → 31 May 2022
Targeting pathways involved in ZEB1-driven EMT in an aggressive subtype of colorectal cancer
Fellow: Sven Jonckheere
Funding: Research Foundation - Flanders (FWO)
01 January 2021 → 31 December 2024
Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 31 October 2019
The metastic niche: preparation, function and translational evidence of a permissieve micro environment for cancer dissemination
Funding: Regional and community funding: Special Research Fund
01 January 2011 → 31 December 2014
The metazoan cadherin superfamily: evolution, structures and functions
Funding: Research Foundation - Flanders (FWO)
01 October 2015 → 30 September 2019
The nuclear balance of ZEB transcription factors – a driver of cellular plasticity for initiation and progression of melanoma.
Fellow: Kenneth Bruneel
Funding: Research Foundation - Flanders (FWO)
01 October 2017 → 31 March 2018
The role of ZEB1 in basal breast cancer
Fellow: Eva De Smedt
Funding: Funding by bilateral agreement (private and foundations)
01 January 2017 → 31 December 2019
The role of ZEB transcription factors in epigenetic chromatin remodeling and gene expression regulation during EMT
Funding: Research Foundation - Flanders (FWO)
01 October 2016 → 15 May 2021
The role of ZEB transcription factors in malignant progression and therapy resistance in high grade serous ovarian cancer
Fellow: Nele Loret
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 31 December 2016
Towards improved genetic diagnosis for hereditary breast and ovarian cancer: evolution and challenges
Funding: Funding by bilateral agreement (private and foundations)
01 November 2022 → 31 October 2026
Unbiased exploration of epithelial-mesenchymal plasticity in colorectal cancer reveals role for non-canonical STAT1 signalling
Fellow: Jef Haerinck
Funding: Research Foundation - Flanders (FWO)
01 November 2023 → 31 October 2027
Unraveling the molecular regulation of ZEB driven melanoma plasticity as a basis for anti-melanoma therapy
Fellow: Emma Robert
Funding: Research Foundation - Flanders (FWO)
01 November 2022 → 31 October 2026
Unravelling EMT-controlled aetiology and chemotherapy resistance of ovarian carcinosarcoma
Fellow: Kato De Clercq
Funding: Research Foundation - Flanders (FWO)
01 January 2016 → 31 December 2016
ZEB1 drives melanoma development by bypassing oncogene-induced senescence in melanocytic nevi
Fellow: Niels Vandamme
Funding: Research Foundation - Flanders (FWO)
As
Copromotor
01 November 2024 → 31 October 2028
A computational approach to monitor epithelial-to-mesenchymal plasticity in breast cancer patients through epigenetic analysis of cfDNA.
Fellow: Edoardo Giuili
Funding: Research Foundation - Flanders (FWO)
01 October 2009 → 26 February 2015
Alpha catenins: protein replacement in the fight against cancer invasion and metastasis
Fellow: Koen Tyberghein
Funding: Regional and community funding: IWT/VLAIO
01 November 2021 → 31 October 2025
An alternative more tolerable L-asparaginase variant for the treatment of metastatic breast cancer
Fellow: Evelien Peeters
Funding: Research Foundation - Flanders (FWO)
01 May 2022 → 30 April 2026
A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapies
Funding: Research Foundation - Flanders (FWO)
01 May 2024 → 30 April 2028
FullPicture: Combining Spectral Flow Cytometry with High-Speed Cell Imaging to enable comprehensive profiling of plant and animal cells and their components in real time.
Funding: Research Foundation - Flanders (FWO)
15 October 2007 → 30 September 2009
Functional role of the Snail family of transcription factors in cancer progression in vivo
Funding: Regional and community funding: Special Research Fund
01 October 2009 → 26 February 2015
In silico identification of functional transcription factor binding sites in higher eukaryotes
Funding: Regional and community funding: IWT/VLAIO
01 January 2018 → 31 December 2022
Relation between energy and redox metabolism and regulated necrosis during EMT: an opportunity for experimental cancer therapy.
Fellow: Hanne Verschuere
Funding: Research Foundation - Flanders (FWO)
01 January 2008 → 31 October 2013
Role of cell adhesion-mediated signaling in craniofacial malformations: an integrated molecular and morphological study
Funding: Regional and community funding: Special Research Fund
01 January 2013 → 31 December 2015
Role of ZEB2 in T-cell acute lymphoblastic leukemia (T-ALL) initiation and Progression
Funding: Funding by bilateral agreement (private and foundations)
01 January 2013 → 31 December 2016
Roles of Nanos family members in cancer progression
Funding: Funding by bilateral agreement (private and foundations)
01 May 2022 → 30 April 2026
SpatialConnect: linking tissue biology to the new era of single-cell spatial transcriptomics
Funding: Research Foundation - Flanders (FWO)
01 July 2011 → 30 April 2016
Structural and functional characterization of class-II classic cadherins end delta-protocadherins
Funding: Regional and community funding: Special Research Fund
01 November 2020 → 31 October 2024
The peritoneal microenvironment in the pathogenesis of colorectal peritoneal carcinomatosis: the role of MMT and cancer-associated fibroblasts
Fellow: Jesse Demuytere
Funding: Research Foundation - Flanders (FWO)
As
Fellow
01 October 2007 → 30 September 2008
The role of E-cadherin in epithelial differentiation and growth control: mechanisms of transcriptional regulation and abnormal gene expression in human tumors
Fellow: Geert Berx
Funding: Research Foundation - Flanders (FWO)
As
Researcher
01 October 2021 → 30 September 2025
The use of a less toxic alternative asparaginase variant to treat metastatic breast cancer
Funding: Regional and community funding: Special Research Fund